164 related articles for article (PubMed ID: 12130517)
1. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling.
Nikolova M; Musette P; Bagot M; Boumsell L; Bensussan A
Blood; 2002 Aug; 100(3):1019-25. PubMed ID: 12130517
[TBL] [Abstract][Full Text] [Related]
2. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.
Dietrich J; Cella M; Colonna M
J Immunol; 2001 Feb; 166(4):2514-21. PubMed ID: 11160312
[TBL] [Abstract][Full Text] [Related]
3. [Epidermotropic T cell lymphomas as models for tumor progression].
Bagot M; Bensussan A
Med Sci (Paris); 2006 Feb; 22(2):192-6. PubMed ID: 16457762
[TBL] [Abstract][Full Text] [Related]
4. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
5. Significance of circulating T-cell clones in Sezary syndrome.
Ortonne N; Huet D; Gaudez C; Marie-Cardine A; Schiavon V; Bagot M; Musette P; Bensussan A
Blood; 2006 May; 107(10):4030-8. PubMed ID: 16418328
[TBL] [Abstract][Full Text] [Related]
6. Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).
Kirwan SE; Burshtyn DN
J Immunol; 2005 Oct; 175(8):5006-15. PubMed ID: 16210603
[TBL] [Abstract][Full Text] [Related]
7. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.
Poszepczynska-Guigné E; Schiavon V; D'Incan M; Echchakir H; Musette P; Ortonne N; Boumsell L; Moretta A; Bensussan A; Bagot M
J Invest Dermatol; 2004 Mar; 122(3):820-3. PubMed ID: 15086570
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor.
Christensen MD; Geisler C
Scand J Immunol; 2000 Jun; 51(6):557-64. PubMed ID: 10849365
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients.
Bensussan A; Remtoula N; Sivori S; Bagot M; Moretta A; Marie-Cardine A
J Invest Dermatol; 2011 Apr; 131(4):969-76. PubMed ID: 21191411
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
Young NT; Uhrberg M; Phillips JH; Lanier LL; Parham P
J Immunol; 2001 Mar; 166(6):3933-41. PubMed ID: 11238638
[TBL] [Abstract][Full Text] [Related]
11. Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas.
Nikolova M; Bagot M; Boumsell L; Bensussan A
Leuk Lymphoma; 2002 Apr; 43(4):741-6. PubMed ID: 12153159
[TBL] [Abstract][Full Text] [Related]
12. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
13. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
Anfossi N; Doisne JM; Peyrat MA; Ugolini S; Bonnaud O; Bossy D; Pitard V; Merville P; Moreau JF; Delfraissy JF; Dechanet-Merville J; Bonneville M; Venet A; Vivier E
J Immunol; 2004 Dec; 173(12):7223-9. PubMed ID: 15585844
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor.
Bellón T; Kitzig F; Sayós J; López-Botet M
J Immunol; 2002 Apr; 168(7):3351-9. PubMed ID: 11907092
[TBL] [Abstract][Full Text] [Related]
15. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands.
Carena I; Shamshiev A; Donda A; Colonna M; Libero GD
J Exp Med; 1997 Nov; 186(10):1769-74. PubMed ID: 9362537
[TBL] [Abstract][Full Text] [Related]
17. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
[TBL] [Abstract][Full Text] [Related]
18. Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor.
Magazin M; Poszepczynska-Guigné E; Bagot M; Boumsell L; Pruvost C; Chalon P; Culouscou JM; Ferrara P; Bensussan A
J Invest Dermatol; 2004 Jan; 122(1):111-8. PubMed ID: 14962098
[TBL] [Abstract][Full Text] [Related]
19. CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
Moins-Teisserenc H; Daubord M; Clave E; Douay C; Félix J; Marie-Cardine A; Ram-Wolff C; Maki G; Beldjord K; Homyrda L; Michel L; Bensussan A; Toubert A; Bagot M
J Invest Dermatol; 2015 Jan; 135(1):247-257. PubMed ID: 25158034
[TBL] [Abstract][Full Text] [Related]
20. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
